The Can Do Multiple Sclerosis Outcomes Study: Study Design to Evaluate Program Outcomes
Background: Assessment of self-efficacy has been a focus of Can Do MS programs given prior research showing associations between higher...
Evaluating the Impact of Fatigue Symptoms on Work Productivity and Activity Impairment Using Longitudinal Data from the Phase III Optimum Study
Background: Fatigue is a common symptom experienced by patients with Multiple Sclerosis (MS); and, the impact of fatigue on work...
Factors Associated with Stigma in People with Multiple Sclerosis.
Background: Social stigma is a common experience among persons with multiple sclerosis (PwMS), and it may impact daily functioning, quality...
Trends in Absence Time and Payments Due to Long- and Short-Term Disability and Workers’ Compensation for Employees with Multiple Sclerosis
Background: Employers offer a variety of absence benefits. It is unknown how benefit design impacts the use of the benefits, the length of...
Assessing the Impact of Disease Activity and Fatigue Symptom on Work Productivity and Activity Impairment in Patients with Relapsing Multiple Sclerosis
Background: Multiple Sclerosis (MS) is well known to reduce work productivity and adversely affect usual activities. Although previous...
Improving Communication about Multiple Sclerosis: The MS-Support Decision Aid
Background: Good communication between patients and their health care provider (HCP) is essential for shared decision making (SDM). We...
Differences in Expected Number of Clinical Management Events before and during Treatment with Sphingosine-1-Phosphate Receptor Modulators for Multiple Sclerosis
Background: Sphingosine-1-phosphate receptor modulators (S1Ps), a class of oral disease-modifying therapies (DMTs) for multiple sclerosis...